Abstract
Forty-four pathologic specimens of 39 bladder cancer patients were analyzed immunohistochemically with DO7 monoclonal antibody to detect over-expression of mutant p 53 gene. The findings were interpreted by correlating with patient age, sex, cigarette smoking, number and macroscopic appearance of tumour, histological tumour grade, muscular invasion, vascular invasion, necrosis and urothelial atypia or dysplasia. Mutant p53 gene was over-expressed in 8 (18.2%) specimens. Statistically significant correlation with grdde, vascular invasion, necrosis and patient sex was found with p53 over-expression. Available follow-up data were insufficient to draw a conclusion about the prognostic role of p53 over-expression. Prospective studies with larger number of patients are needed to define the exact place of nuclear p53 over-expression in transitional cell bladder cancer.
References
Batsakis, J. G., El-Naggar, A. K.: p53: 15 years after discovery.Advanc. Anat. Pathol., 2, 71 (1995).
Esrig, D., Spruck, E. D., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A., Cote, R. J.: p53 nuclear protein accumulation correlates with over-expression and mutations in the p53 gene, tumor grade and stage in bladder cancer.Am. J. Pathol., 143, 1389 (1993).
Fradet, Y.: Molecular and immunologic approaches in the management of bladder cancer.Urol. Clin. North Am., 8, 515 (1991).
Gardiner, R. A., Walsh, M. D., Allen, V., Rahman, S., Samaratunga, M. L. T. H., Seymour, G. J., Lavin, M. F.: Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression.Br. J. Urol., 73, 526 (1994).
Heney, N. M., Nocks, B. N., Daly, J. J., Proud, G. R., Jr., Mewell, J. R. Grissin, P. P., Perrone, T. L., Szyfelbein, W. A.: Ta and T1 bladder cancer: Location, recurrence and progression.Br. J. Urol. 54, 152 (1982).
Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C. C.: p53 mutations in human cancer.Science, 253, 49 (1991).
Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value.Int. J. Cancer, 53, 365 (1993).
Mellon, K., Wilkinson, S., Vickers, J., Robinson, M. C., Shenton, B. K., Neal, D. E. Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder.Br. J. Urol., 73, 522 (1994).
Miyao, N., Tsai, Y. C., Lerner, S. P., Spruck, C. H., Gonzales-Zulueta, M., Nichols, P. W., Skinner, D. G., Jones, P. A.: Role of chromosome 9 in human bladder cancer.Cancer Res., 53, 4066 (1994).
Ro, J. Y., Staerkel, G. A., Ayala, A. G.: Cytologic and histologic features of superficial bladder cancer.Urol. Clin. North Am 19, 435 (1992).
Sarkis, A. S., Dalbagni, G., Cordon-Cardon, C., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., Reuter, V. E.: Nuclear over-expression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression.JNCI 85, 53 (1993).
Sarkis, A. S., Dalbagni, G., Cordon-Cardon, C., Melamed, J., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., Reuter, V. E.: Association of p53 nuclear over-expression and tumor progression in carcinoma in situ.J. Urol., 152, 388 (1994).
Sarosdy, M. F.: Principles of intravesical chemotherapy and immunotherapy.Urol. Clin. North Am., 19, 509 (1992).
Sidransky, D., Von, Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., Vogelstein, B.: Identification of p53-gene mutations in bladder cancers and urine samples.Science 252, 706 (1991).
Spruck, C. H., Rideout, W. M., Olumi, A. F., Ohnseit, P. F., Yang, A. S., Tsai, Y. C., Nichols, P. W., Horn, T., Hermann, G. G., Steven, K., Ross, R. K. Mimi, C. Y., Jones, P. A.: Distinct pattern of p53 mutations in bladder cancer: Relationship to tobacco usega.Cancer Res., 53, 1162 (1993).
Thomas, D. J., Robinson, M. C., Charlton, R., Wilkinson, S., Shenton, B. K., Neal, D. E.: p53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.Br. J. Urol., 73, 533 (1994)
Thompson, S. J., Mellon, K., Charlton, R. G., Marsh, C., Robinson, M., Neal, D. E.: p53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia.Br. J. Urol., 69, 609 (1992).
Wright, C., Mellon K., Johnston, P., Lane, D. P., Harris, A. L., Horne, C. H. W., Neal, D. E.: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder..Br. J. Cancer, 63, 967 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sinik, Z., Alkibay, T., Ataoĝlu, Ö. et al. Correlation of nuclear p53 over-expression with clinical and histopathological features of transitional cell bladder cancer. International Urology and Nephrology 29, 25–31 (1997). https://doi.org/10.1007/BF02551413
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02551413